Co-Authors
This is a "connection" page, showing publications co-authored by Sreedhar Subramanian and Thomas Conley.
Connection Strength
1.260
-
Prevalence of Covid-19 Symptoms Among Inflammatory Bowel Disease Patients Treated with Biological Agents. J Crohns Colitis. 2020 Dec 02; 14(12):1794-1795.
Score: 0.916
-
Letter: Covid-19-re-initiating clinical services for chronic gastrointestinal diseases. How and when? Aliment Pharmacol Ther. 2020 10; 52(8):1414-1415.
Score: 0.226
-
Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study. Aliment Pharmacol Ther. 2021 06; 53(11):1236-1240.
Score: 0.059
-
Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study. Lancet Gastroenterol Hepatol. 2021 04; 6(4):271-281.
Score: 0.058